Glaucoma, Neovascular
Information
- Disease name
- Glaucoma, Neovascular
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT01908816 | Completed | Phase 3 | An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases. | September 26, 2013 | January 8, 2016 |
| NCT01922154 | Completed | Phase 4 | Intravitreous Ranibizumab as Adjunctive Treatment for Trabeculectomy in Neovascular Glaucoma | February 2009 | December 2012 |
| NCT02396316 | Completed | Phase 3 | Japanese Phase 3 Study of Aflibercept in Neovascular Glaucoma Patients | April 2, 2015 | September 6, 2016 |
| NCT02647515 | Completed | Phase 4 | Intravitreal Ranibizumab Injection as Adjuvant in the Treatment of Postvitrectomy Diabetic Vitreous Hemorrhage Accompanied by Neovascular Glaucoma | January 2013 | December 2014 |
| NCT03187418 | Completed | N/A | Treatment Outcomes of MicroPulse Trans-scleral Cyclophotocoagulation in Uncontrolled Glaucoma | June 19, 2017 | February 15, 2020 |
| NCT03639675 | Completed | Phase 3 | Study to Learn How the Drug Aflibercept Works in in Japanese Patients With Increased Eye Pressure That is Caused by New Blood Vessels Growing in the Eye (Neovascular Glaucoma or NVG). Safety of the Drug and Patients' Tolerability of the Drug Injection is Also Studied | October 3, 2018 | March 14, 2019 |
| NCT04214847 | Completed | N/A | The Outcome of Ahmed Glaucoma Valve in Difficult Glaucoma Cases | February 1, 2012 | July 15, 2014 |
| NCT04215575 | Completed | N/A | Baerveldt (BGI) Valve Versus Ahmed(AGV) Valve in Management of Difficult Glaucoma Cases | January 1, 2014 | December 20, 2016 |
| NCT04381611 | Enrolling by invitation | INTEGRAL Study: A Longitudinal Study of Surgeries and Lasers in Glaucoma: Long-term Results and Success Predictors Analysed From a Large-scale Retrospective and Prospective Glaucoma Register | January 15, 2019 | January 15, 2030 | |
| NCT05593354 | Not yet recruiting | MicroPulse TLT - UK Study | May 1, 2023 | December 2025 | |
| NCT02914626 | Unknown status | Phase 3 | Intravitreal Ranibizumab (Lucentis®) for Neovascular Glaucoma- a Randomized Controlled Study | October 2016 | October 2018 |
| NCT03648814 | Unknown status | N/A | Intracameral Versus Intravitreal Bevacizumab Injection in NVG: RCT | August 1, 2018 | July 1, 2023 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D015355